Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the first quarter ended March 31, 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results